TESTOSTERONE THERAPY
Testosterone Cypionate Injections
Prescription testosterone injections for adults with documented testosterone deficiency who need a flexible, closely monitored replacement option.
What it is
Testosterone cypionate is a long-acting form of testosterone given by injection. It is prescribed after symptoms, medical history, and repeat laboratory testing support a diagnosis of testosterone deficiency.
How it works
The cypionate ester releases testosterone gradually after an intramuscular or subcutaneous injection. A clinician selects the dose and interval from baseline labs, symptoms, and safety markers. Repeat testing guides adjustments over time.
Who it is for
- Adults with repeat testing that confirms low testosterone
- Patients who prefer an adjustable injection schedule
- People able to complete scheduled lab monitoring
Mechanism in depth
Cypionate is an oil-based ester of testosterone. After injection into muscle or subcutaneous fat, it releases testosterone gradually as tissue esterases cleave the ester bond. Testosterone circulates bound to sex hormone binding globulin (SHBG) and albumin, with a small free fraction that binds androgen receptors in muscle, brain, bone, and sexual tissues. A portion also aromatizes to estradiol, which is why estrogen management is part of the picture. Half-life is roughly eight days, which is why weekly or twice-weekly dosing is common.
What outcomes to expect
Many symptomatic patients notice steadier energy and improved mood within three to six weeks. Libido, morning erections, and workout recovery may improve over eight to twelve weeks. Muscle mass and body composition changes take three to six months of consistent dosing plus training. Your physician tracks symptoms and labs, not just numbers on a bottle — some patients feel their best in the mid-range, not the top of the reference interval.
Individual response varies. GPLX does not guarantee results. Your physician sets expectations based on your health history and lab findings.
Common side effects
The most common side effects are acne, oily skin, water retention, mild mood swings during the first few weeks, elevated hematocrit, and estrogen-related symptoms such as tender breast tissue if aromatization is high. Injection sites can develop mild soreness. Long-term risks that require monitoring include cardiovascular events, prostate changes in older men, and suppression of natural fertility.
Monitoring schedule
GPLX typically checks a baseline panel, then labs at six to eight weeks to see how you respond to the starting dose. After that, labs and a check-in visit every three to six months. Ongoing monitoring includes total and free testosterone, estradiol, hematocrit, PSA in men over forty, and a lipid and metabolic review at least once a year.
Not appropriate if
Testosterone injections are not appropriate if you have untreated prostate or breast cancer, uncontrolled polycythemia, severe untreated sleep apnea, an active desire for fertility in the next year, an unstable cardiovascular condition, or if pregnancy is possible. Your physician reviews your full history before starting.
Biomarkers reviewed with this treatment
Your physician reviews these markers before and during therapy. Click any marker for a plain-English explanation of what it measures and why it matters.
This treatment is only available after a physician consultation. Membership $39.99/month; consultation $30. Labs and medications billed separately.
Start Your Consultation